Danimer Scientific Q1 2024 GAAP EPS $(0.26) Beats $(0.31) Estimate, Sales $10.224M Miss $11.063M Estimate
Portfolio Pulse from Benzinga Newsdesk
Danimer Scientific (DNMR) reported Q1 2024 earnings with a GAAP EPS of $(0.26), surpassing the $(0.31) estimate, indicating a 16.13% beat and a 27.78% improvement from last year's $(0.36) per share. However, their Q1 sales of $10.224M fell short of the $11.063M estimate by 7.59%, marking a 14.27% decline from the previous year's $11.926M.
May 07, 2024 | 8:33 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Danimer Scientific's Q1 2024 earnings outperformed EPS estimates but missed on sales, indicating mixed financial health.
The beat on EPS estimates suggests operational efficiency or cost control, potentially positive for investor sentiment. However, the miss on sales forecasts could indicate revenue challenges or market competition, which might temper investor enthusiasm. The mixed results present a nuanced outlook, hence the neutral score.
CONFIDENCE 85
IMPORTANCE 75
RELEVANCE 90